epirubicin has been researched along with Cancer of Testis in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, HP; Lo, YL; Tu, WC | 1 |
| Avilés, A; Cleto, S; Huerta-Guzmán, J; Nambo, MJ; Neri, N | 1 |
| Colombat, P; Desablens, B; Escoffre, M; Gandhour, C; Haillot, O; Harousseau, JL; Jacob, C; Le Prise, PY; Lefrancq, T; Leloup, R; Linassier, C; Lucas, V; Tabuteau, S | 1 |
| Biron, P; Bui, B; Caty, A; Culine, S; Curé, H; De Revel, T; Delva, R; Droz, JP; Duclos, B; Fizazi, K; Gligorov, J; Gomez, F; Gravis, G; Guillemaut, S; Lotz, JP; Peny, J; Provent, S; Ségura, C; Théodore, C; Viens, P | 1 |
| Grunenberg, B; Krischke, W; Niederle, N; Schmidt, CG; Schütte, J; Seeber, S | 1 |
| Fichtner, I; Goan, SR; Herrmann, F; Just, U; Karawajew, L; Krause, KP; Schultze, W; von Harsdorf, S; von Schilling, C | 1 |
| Bokemeyer, C; Dunn, T; Harstrick, A; Lerch, T; Poliwoda, H; Schmoll, HJ | 1 |
| Agrawal, AK; Gupta, NP; Hemal, AK; Nair, M; Sood, S | 1 |
| Bekradda, M; Bensmaïne, MA; Brain, E; Cvitkovic, E; Di Palma, M; Garrino, C; Goupil, A; Misset, JL; Soulié, P | 1 |
| Fischer, L; Foss, HD; Koch, HC; Korfel, A; Thiel, E | 1 |
| Casper, J; Harstrick, A; Köhne-Wömpner, H; Poliwoda, H; Schmoll, HJ; Wilke, H | 1 |
| Bokemeyer, C; Burk, K; Dölken, G; Harstrick, A; Poliwoda, H; Schmoll, HJ; Schöber, C; Stahl, M; Wilke, H; Wömpner, CK | 1 |
1 review(s) available for epirubicin and Cancer of Testis
| Article | Year |
|---|---|
Malignant mesothelioma of the tunica vaginalis testis: a report of two cases and review of literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diagnosis, Differential; Drug Administration Schedule; Epirubicin; Humans; Ifosfamide; Male; Mesothelioma; Testicular Neoplasms; Testis | 1999 |
5 trial(s) available for epirubicin and Cancer of Testis
| Article | Year |
|---|---|
Rituximab and dose-dense chemotherapy in primary testicular lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Epirubicin; Humans; Longitudinal Studies; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Rituximab; Survival Rate; Testicular Neoplasms; Vincristine | 2009 |
Stage I-IIE primary non-Hodgkin's lymphoma of the testis: results of a prospective trial by the GOELAMS Study Group.
Topics: Adult; Age Factors; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Prospective Studies; Recurrence; Testicular Neoplasms; Time Factors; Vincristine | 2002 |
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Stem Cell Transplantation; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome | 2005 |
Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Dactinomycin; Drug Resistance, Neoplasm; Drug Therapy, Combination; Epirubicin; Etoposide; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Salvage Therapy; Testicular Neoplasms; Thrombocytopenia; Treatment Outcome; Vinblastine; Vinorelbine | 1999 |
High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: a phase II study.
Topics: Combined Modality Therapy; Drug Administration Schedule; Drug Evaluation; Epirubicin; Humans; Male; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Testicular Neoplasms | 1990 |
6 other study(ies) available for epirubicin and Cancer of Testis
| Article | Year |
|---|---|
The Use of a Liposomal Formulation Incorporating an Antimicrobial Peptide from Tilapia as a New Adjuvant to Epirubicin in Human Squamous Cell Carcinoma and Pluripotent Testicular Embryonic Carcinoma Cells.
Topics: Animals; Anti-Infective Agents; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Hepcidins; Humans; Liposomes; Male; Reactive Oxygen Species; Testicular Neoplasms; Tilapia | 2015 |
4'-Epi-Doxorubicin -- a clinical phase-II trial in solid tumors.
Topics: Adult; Aged; Alopecia; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Kidney Neoplasms; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Testicular Neoplasms; Thrombocytopenia | 1984 |
The severe combined immunodeficient-human peripheral blood stem cell (SCID-huPBSC) mouse: a xenotransplant model for huPBSC-initiated hematopoiesis.
Topics: Adult; Animals; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Breast Neoplasms; Cell Line; Chimera; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Fibroblasts; Fluorouracil; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Interleukin-3; Lymphoid Tissue; Male; Mice; Mice, SCID; Middle Aged; Ovarian Neoplasms; Rats; Severe Combined Immunodeficiency; Testicular Neoplasms; Transplantation, Heterologous | 1995 |
Modulation of cytostatic drugs by nifedipine in two heterotransplanted human testicular-cancer cell lines differing in their sensitivity to standard agents.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cell Division; Cell Line; Cisplatin; Doxorubicin; Drug Interactions; Drug Resistance; Epirubicin; Etoposide; Germinoma; Humans; Male; Membrane Glycoproteins; Mice; Mice, Nude; Neoplasm Transplantation; Nifedipine; Testicular Neoplasms; Transplantation, Heterologous; Vinblastine | 1994 |
Testicular germ cell tumor with rhabdomyosarcoma successfully treated by disease-adapted chemotherapy including high-dose chemotherapy: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Cell Differentiation; Cisplatin; Combined Modality Therapy; Diphosphonates; Epirubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Liver Neoplasms; Lumbar Vertebrae; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Multiple Primary; Orchiectomy; Pamidronate; Remission Induction; Rhabdomyosarcoma; Seizures; Seminoma; Spinal Neoplasms; Teratoma; Testicular Neoplasms; Transplantation, Autologous | 2001 |
Comparative activity of four anthracyclines against heterotransplanted germ cell tumor lines.
Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Cisplatin; Doxorubicin; Epirubicin; Humans; Ifosfamide; Male; Mice; Mitoxantrone; Neoplasm Transplantation; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured; Vinblastine | 1990 |